Interpace Biosciences (IDXG) Reports Q4 EPS of $0.82

Interpace Biosciences (OTC: IDXG) reported Q4 EPS of $0.82.Revenue for the quarter came in at $9.22 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• After-Hours Stock Movers: AVAV, PRAX, VSH, CNXC, SHAZ
• Santacruz Silver reports employee fatality at Bolivia's Reserva mine